Public Company News
Lufax Granted Extension by NYSE for Filling the 2024 Annual Report on Form 20-F
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Lufax Holding Ltd (NYSE: LU and HKEX: 6623), ("Lufax", or the "Company"), a leading financial services enabler for small business owners inChina, today announced that the New York Stock Exchange (the "NYSE") has granted the Company an extension throughApril...
2025-10-30 19:00
3525
JinkoSolar's Subsidiary, Jinko Solar Co., Ltd., Announces Third Quarter 2025 Unaudited Financial Results
SHANGRAO, China, Oct. 30, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that its majority-owned principal operating subsidiary,Jinko Solar Co., Ltd. ("J...
2025-10-30 18:50
5099
SuperX and Teamsun Announce Formation of "SuperX Global Service" Joint Venture
The Singapore-based joint venture, majority-controlled by SuperX, is established to provide end-to-end AI infrastructure services to global clients, completing SuperX's "product + service" full-lifecycle value chain. SINGAPORE, Oct. 30, 2025 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: ...
2025-10-30 18:35
3195
Solidion Technology Secures $1 Million Non-Dilutive Bridge Financing from Existing Shareholder
Company Reaffirms Commitment to Protect Shareholder Value and Pursue Strategic, Long-Term Capital Partners DALLAS, Oct. 30, 2025 /PRNewswire/ -- Solidion Technology Inc. (Nasdaq: STI), an advanced battery technology solutions provider, today announced that it has entered into a$1,000,000 non-dil...
2025-10-30 18:00
2765
TAL Education Group Announces Unaudited Financial Results for the Second Fiscal Quarter Ended August 31, 2025 and Issues Notice of Annual General Meeting
BEIJING, Oct. 30, 2025 /PRNewswire/ -- TAL Education Group (NYSE: TAL) ("TAL" or the "Company"), a smart learning solutions provider inChina, today announced its unaudited financial results for the second quarter of fiscal year 2026 ended August 31, 2025 and issued notice of Annual General Meeting...
2025-10-30 17:00
3698
CNOOC Limited Achieves Steady Project Progress and Production Growth in Q3 2025
HONG KONG, Oct. 30, 2025 /PRNewswire/ -- CNOOC Limited (the "Company" or "CNOOC Limited", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announced its operating results for the third quarter of 2025. In the first three quarters of 2025, CNOOC Limited continued to increase...
2025-10-30 16:55
3869
Hyundai Motor Group Advances Hydrogen Vision in Dialogue at APEC CEO Summit Korea 2025
* Hyundai Motor Group engages in strategic dialogue in the session "Hydrogen, Beyond Mobility, New Energy for Society" at APEC CEO Summit Korea 2025 * Vice Chair Jaehoon Chang emphasizes hydrogen's role as a catalyst of carbon neutrality and strategic energy carrier * The Group calls for glo...
2025-10-30 16:26
2175
Sun Life Survey Reveals Financial Security Tops Legacy Planning Priorities But Families Worry Wealth Won't Last Beyond Next Generation
* Seven in 10 say ensuring their family's financial security is the most important element of legacy planning. * 59% want the wealth they leave behind to be invested in long-term wealth creation. * Nearly two-thirds (60%) fear their wealth may not be preserved beyond their children's genera...
2025-10-30 16:22
2403
Clarivate Pulse of the Library Report Reveals Link Between AI Literacy, AI Implementation and Confidence
Drawing on insights from over 2,000 librarians representing academic, national and public libraries globally, the report offers an up-to-date view of how they are adapting to rapid change LONDON, Oct. 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative...
2025-10-30 16:03
1472
U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)
* The U.S. FDA approved STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) as interchangeable with the reference products PROLIA® (denosumab) and XGEVA® (denosumab), respectively, for all approved indications, effective as ofOctober 29, 2025 * The interchangeability (IC) designations o...
2025-10-30 15:28
3771
Hyundai Motor Breaks Ground on Hydrogen Fuel Cell Production Facility in Korea
* Hyundai Motor holds groundbreaking ceremony for its new hydrogen fuel cell production facility in Ulsan, Korea * With an investment of KRW 930 billion, the facility—set for completion in 2027—will mass-produce 30,000 fuel cell units annually, along with PEM electrolyzers … Improved fuel cel...
2025-10-30 15:17
2134
Electrolux Group Interim report Q3 2025
STOCKHOLM, Oct. 30, 2025 /PRNewswire/ -- Highlights of the third quarter of 2025 * Net sales amounted to SEK 32,318m (33,286) with an organic sales growth of 4.6% (6.2), mainly driven by strong growth inNorth America. * Operating income improved to SEK 890m (349) corresponding to an operating...
2025-10-30 14:35
1436
United Imaging Healthcare Q3 2025 Results: In The First Three Quarters Of 2025, Overseas Revenue Up 42% YoY
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in advanced medical imaging and radiotherapy equipment, has released its financial results for the first three quarters of 2025, showcasing robust financial performance. During this period, the compa...
2025-10-30 13:58
2909
Samyang Corporation Showcases Expanded Applications of Its AI-Based Standardized Sugar Reduction Solution at U.S. Food Expo
* Participating in "Supply Side Global 2025," held in Las Vegas, U.S., from October 29 to 30 * Expanding the application of its "3S Solution," utilizing specialty ingredients, from cereal bars to pectin gummies SEOUL, South Korea, Oct. 30, 2025 /PRNewswire/ -- Samyang Corporation (CEO Nag-hyu...
2025-10-30 13:28
2299
Electric Two-Wheeler Brand POWELLDD Achieves Rapid Growth in Vietnam: Launching Three New Models, Boasting 20 Brand Stores Nationwide
GUIGANG, China, Oct. 29, 2025 /PRNewswire/ -- In October 2025, the global electric two-wheeler brand POWELLDD made its grand debut, launching three strategic models simultaneously and rapidly expanding its channel network. It has opened over 20 brand stores inVietnam to offer higher-quality optio...
2025-10-30 13:24
2317
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
* Everest Medicines acquired an exclusive license to develop, manufacture, and commercialize VIS-101 inGreater China, Singapore, South Korea, and certain Southeast Asian countries. * Under the assigned exclusive license, Everest Medicines will make an upfront payment ofUS$7 million (equivalen...
2025-10-30 11:05
2273
Sany Heavy Industry Co., Ltd.'s Hong Kong IPO: "A+H" Dual Platform Anchors a New Journey of Globalization
HONG KONG, Oct. 30, 2025 /PRNewswire/ -- On October 28, Sany Heavy Industry Co., Ltd. (6031.HK) was officially listed on the Main Board of HKEX (Hong Kong Exchanges and Clearing Limited). The listing marks a pivotal step in the company's capital deployment and globalization strategy, coming 21 y...
2025-10-30 10:53
4049
Innovation in the Spotlight: Microvast at All-Energy Australia 2025
MELBOURNE, Australia, Oct. 30, 2025 /PRNewswire/ -- Microvast Holdings, Inc. (NASDAQ: MVST) ("Microvast", the "Company" or "we"), a global leader in advanced battery technologies, will showcase its suite of high-performance battery products at All-Energy Australia 2025. The international energy ...
2025-10-30 10:24
2194
Jenscare released its multi-product portfolio's, including LuX-Valve Plus TRINITY study, JensClip and Ken-Valve, remarkable clinical outcomes at TCT 2025 in the U.S.
BEIJING, Oct. 29, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company, recently released 6-month follow-up results of TRINITY Trial of LuX-Valve Plus, a promising self-developed TTVR system, and 1-year outcomes and c...
2025-10-30 09:00
1661
Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development
-In head-to-head non-human primate (NHP) studies, average observed half-life of ASC36 was approximately15 days, 3-fold longer than petrelintide, which supports once-monthly subcutaneous (SQ) dosing in humans. -ASC36 demonstrated approximately 91% greater relative body weight reduction compared t...
2025-10-30 08:10
2261
Week's Top Stories
Most Reposted
Digital Identity Co. Modernizes Thailand Immigration Bureau Services with AWS
[Picked up by 314 media titles]
2026-05-28 15:06The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 291 media titles]
2026-05-26 10:30
Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific
[Picked up by 289 media titles]
2026-05-28 17:34
Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
[Picked up by 288 media titles]
2026-05-27 09:16
ASEAN Business Advisory Council (ASEAN-BAC) and AVPN Establish Regional Platform to Strengthen Corporate Social Investment and Cross-Sector Collaboration Across Southeast Asia
[Picked up by 288 media titles]
2026-05-28 10:06Most Read
ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
2026-05-26 08:40
6385
Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
2026-05-27 09:16
6360
NYSE Content Update: Mastercard Celebrates Two Decades as NYSE-Listed Company
2026-05-26 21:04
6352
/DISREGARD RELEASE: Yangzhou Home Ka Crafts Co., Ltd./
2026-05-29 09:19
6151
